Generate a tailored SOP for Dr. Erik Dreaden. Improve your application with a focused, well-structured draft.
Erik C. Dreaden joined the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University in 2017. He holds a joint faculty appointment in the Department of Pediatrics at the Emory University School of Medicine, collaborating with researchers at Children's Healthcare Atlanta Aflac Center Cancer Blood Disorders. Dr. Dreaden's research aims to apply principles of molecular nanoscale engineering to improve the therapeutic potential of drug combinations, vaccines, and immunotherapies directed towards pediatric and adult cancers. Before joining Emory and Georgia Tech, he was a postdoctoral fellow at the Koch Institute for Integrative Cancer Research at MIT, where his research focused on the development of polymer-based technologies for nucleic acid and rational combination cancer therapies. He is a member of the Cancer Immunology Research Program at the Winship Cancer Institute of Emory University, and holds memberships in several professional organizations including the Biomedical Engineering Society and the American Association for Cancer Research.
Department of Computer Science: GRE scores are optional for Fall 2026.